MATERNAL HEALTH CHALLENGE; GHANA
PROVEN INTERVENTION TO BE DISTRIBUTED
Misoprostol.
Learn more about the Maternal Health Challenge and how the distribution of Misoprostol, a $3 drug that can prevent maternal deaths from postpartum hemorrhage, could save thousands of lives.
DISTRIBUTION MODEL INNOVATION
The Oninku Health Foundation (OHF) is a new venture that seeks to address the occurrence of postpartum hemorrhage (PPH) in rural communities of Ghana through training of traditional birth attendants (TBAs). The venture will utilize multiple approaches in distributing and creating awareness about Misoprostol to curb PPH. Due to Ghana’s regulations in the handling of Misoprostol, the venture will leverage the existence of district health facilities to serve as a distributing unit for women. The drug supply will be integrated with antenatal care visits (ANC).
OHF will subsequently raise awareness about the drug through community education activities on maternal health. With technical support from the Ghana Health Service (GHS), OHF will train TBAs on how to administer Misoprostol, and also empower them to have a full set of tools with the proprietary community health box.
PILOT AND SCALING GOALS
Train 120 Traditional Birth Attendants during the pilot phase
Reach 1,200 women during the pilot phase
Train 5,000 Traditional Birth Attendants by the end of year 2
Reach 50,000 women by the end of year 2
FOUNDING TEAM
Samuel Oninku - Founding Member
Godwin King - Founding Member
Emmanuel Tetteh - Founding Member
Abigail Antwi - Founding Member